U.S. markets open in 9 hours 6 minutes
  • S&P Futures

    4,250.25
    +4.50 (+0.11%)
     
  • Dow Futures

    34,492.00
    +30.00 (+0.09%)
     
  • Nasdaq Futures

    14,020.50
    +26.25 (+0.19%)
     
  • Russell 2000 Futures

    2,336.80
    +2.90 (+0.12%)
     
  • Crude Oil

    71.29
    +0.38 (+0.54%)
     
  • Gold

    1,864.20
    -15.40 (-0.82%)
     
  • Silver

    27.92
    -0.22 (-0.79%)
     
  • EUR/USD

    1.2102
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • Vix

    15.65
    -0.45 (-2.80%)
     
  • GBP/USD

    1.4112
    -0.0005 (-0.03%)
     
  • USD/JPY

    109.7540
    +0.1190 (+0.11%)
     
  • BTC-USD

    39,201.14
    +4,220.22 (+12.06%)
     
  • CMC Crypto 200

    976.76
    +34.94 (+3.71%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    29,118.96
    +170.23 (+0.59%)
     

Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

BEDFORD, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2021 financial results after the close of the market on Thursday, May 6, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

The conference call can be accessed by dialing 1-800-437-2398 (toll-free domestic) or 1-856-344-9206 (international) and providing the conference ID number 6335822. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Executive Director, Investor Relations and Corporate Communications
investorrelations@anika.com